[bransonf]

https://gh.bmj.com/content/3/5/e000850

$5.32-8.87 cost of production depending on the insulin analog.

As noted above, I did not account for R&D and manufacturing capacity.

Regardless, I tried to estimate conservatively at a $12-13 per vial overall cost. My napkin math is certainly wrong.

The point is that Walmart still stands to generate a multi-billion dollar per year profit on the sale of this insulin. (Unless my market capture estimate is wrong by an order of 6+, which it could be)

To be clear, I’m not opposed (in fact grateful) that Walmart is competing in the insulin market. However, I still find it unfortunate that we in the United States pay more for Insulin than any other country in the world, even with this competition.